) filed parallel lawsuits in the International Trade Commission
(ITC) and U.S. federal court to protect its patent landscape from
its international competitor APEX Medical.
This provider of medical equipment to treat and diagnose
sleep-disordered breathing (SDB) filed a patent infringement
lawsuit against Taiwan-based APEX Medical. The lawsuit claims,
among other things, that several APEX Medical products violate
numerous ResMed patents.
Many APEX products such as the APEX WiZARD 210 and WiZARD 220
masks and APEX iCH and XT Fit flow generators among others
infringe ResMed's intellectual property. Thus, ResMed seeks to
recover the damages against the defendant.
We note that ResMed also filed action against Medical Depot
(doing business as Drive Medical Design and Manufacturing), the
distributor of APEX products in the U.S. As per the lawsuit,
ResMed wants to stop any further importation and sales of APEX
products into the U.S.
ResMed currently holds a major position in the worldwide market
for generators, masks, and related accessories for the treatment
of SDB, especially obstructive sleep apnea (OSA). The company
enjoys a competitive edge over other players in the market it
serves. ResMed's ability to compete effectively relies on
its ability to protect its patent landscape.
Considering the SDB market overview, there is massive growth
opportunity driven by lifestyle trends, further penetration and
increasing awareness. Evidently, the company's new generation
products are major growth catalysts. ResMed has had to turn to
litigation to protect its intellectual property. The move is seen
as a coherent decision to spur innovation and new product
With a nominal revision in Zacks Consensus Estimate for the
ongoing fiscal over the last 30 days, the stock carries a Zacks
Rank #3 (Hold). While we remain on the sidelines for ResMed,
other medical stocks such as
) warrant a look. These stocks carry a Zacks Rank #1 (Strong
CEPHEID INC (CPHD): Free Stock Analysis
CYBERONICS INC (CYBX): Free Stock Analysis
GIVEN IMAGING (GIVN): Free Stock Analysis
RESMED INC (RMD): Free Stock Analysis Report
To read this article on Zacks.com click here.